Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.
about
Emerging roles of glycogen synthase kinase 3 in the treatment of brain tumorsExploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer PatientsGene therapy for brain tumors: basic developments and clinical implementationDeregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targetsA critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapyIn vivo models of primary brain tumors: pitfalls and perspectives.Treating malignant glioma in Chinese patients: update on temozolomideKilling me softly--future challenges in apoptosis researchEngineering a Brain Cancer Chip for High-throughput Drug ScreeningTargeting autophagy to sensitive glioma to temozolomide treatmentCarbon nanotubes: an emerging drug carrier for targeting cancer cellsLaeA control of velvet family regulatory proteins for light-dependent development and fungal cell-type specificityIn silico prediction of inhibition of promiscuous breast cancer resistance protein (BCRP/ABCG2)Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell SpheroidsDrug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy.Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier.CSNK1A1 and Gli2 as Novel Targets Identified Through an Integrative Analysis of Gene Expression Data, Protein-Protein Interaction and Pathways Networks in Glioblastoma Tumors: Can These Two Be Antagonistic Proteins?Big data visualization identifies the multidimensional molecular landscape of human gliomas.Delineating the cytogenomic and epigenomic landscapes of glioma stem cell linesIKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastomaPreclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.Pyruvate dehydrogenase kinase as a potential therapeutic target for malignant gliomas.SHORT syndrome in a two-year-old girl - case report.Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation.Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy studyThe small molecule, LLL12, inhibits STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma cells.Effects of AQP5 gene silencing on proliferation, migration and apoptosis of human glioma cells through regulating EGFR/ERK/ p38 MAPK signaling pathway.A Bioengineered Peptide that Localizes to and Illuminates Medulloblastoma: A New Tool with Potential for Fluorescence-Guided Surgical ResectionGlioblastoma models reveal the connection between adult glial progenitors and the proneural phenotypeMicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression.Deficiency of mDia, an actin nucleator, disrupts integrity of neuroepithelium and causes periventricular dysplasia.Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis.Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma.Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells.Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas.Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations.Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin.
P2860
Q21129333-C6C99B2E-F4C8-459F-AB90-C90C4781F72BQ26796590-A32CEB56-5C8D-4E0B-8986-7CB62941768CQ26829086-D17F4830-3DA4-42A0-AC6F-BA820AED7BA4Q26829873-CE33DCDF-43EE-4C86-9FCF-F95A634EBBD6Q26849503-A703751B-5802-407A-915B-44FE12636C03Q26862847-30B24123-22E8-4FF6-BF3F-FA52FD3719D8Q26863755-0F7A0AEE-0089-40C7-A12B-5C9B5798810CQ27025213-5F31E2A5-3273-4240-AF1B-515E8B532E87Q27318558-D675B5AD-107A-4106-988A-3D3EB2F930BDQ28066270-5998F95F-873C-4BB7-8F75-82D437ED982AQ28385865-7423EDA2-3E85-4EB8-9778-6CED1F880198Q28476419-301FAE9F-8F78-44C3-B8EE-E88B78A1F7B1Q28540667-AA54103F-7036-444D-8242-099F04BFD816Q28552301-7BC71CB6-29F6-4E43-A550-42B91F3A45CFQ30424484-0CEFA845-90C0-4372-BCAD-2FCE90335E2EQ30672749-141C5EBD-0C25-49E2-BD42-E513C1073FD4Q30867941-125881EE-C86B-4A16-9650-81BFD616C083Q31085801-67617AAF-5A1D-4012-AF79-BCD9441CFBAAQ31112229-9344A346-C2F2-4352-ADC9-C63BFB724972Q33276239-E37A00D3-0AF4-454B-8FD0-8DD4D04BB3EEQ33572296-551614CC-093F-4EDA-9E50-CB2231289CCBQ33591658-D48F979D-E9C3-47A9-93E5-7F066EC46A8EQ33616649-106D4117-09B1-4C73-8406-0E3A6FDD94F5Q33635374-1FA9C202-5D0B-4BCA-BBC0-91CD49024002Q33640546-0FAA848F-EA32-4AA3-A61C-8EBC1A8174DAQ33675114-EC0AF373-1F4B-4923-9C1F-F65C7A2EBA0CQ33829590-EF6FA27A-8C96-4031-AB48-362A8D160F36Q33883721-EABF8D8B-D0DB-44D4-A973-FA5CAF5509E6Q33888823-3B69953F-14FC-4906-AB78-B6D22C395B64Q33914493-902A504A-6DE8-4B17-B881-6904F63B8115Q33916126-76E25F55-E005-40E4-8D2B-7F77C9ECC129Q33917538-064E165E-BC22-4D60-9F5B-9CDAF9CC4472Q34043243-73E68368-5CDB-41EF-ADEA-AA110C22FB64Q34062017-46DC50E2-BEA8-4A5F-B3ED-49161D023439Q34086373-038494D6-EF89-41FB-82DE-FD0661F3E872Q34102273-EB848B01-8654-4ABE-8E54-D448857904CCQ34140756-994023A2-B2FF-40B5-A1FF-96C34A3765ECQ34146377-F6F00BA3-D716-41DA-B7F8-F93E97A04472Q34160516-ACD0B544-9B6A-414A-BA9C-FC64EFF74A73Q34205345-C1670CF0-7DBB-4678-B15E-D77A20873B2A
P2860
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting brain cancer: advanc ...... nt glioma and medulloblastoma.
@en
Targeting brain cancer: advanc ...... nt glioma and medulloblastoma.
@nl
type
label
Targeting brain cancer: advanc ...... nt glioma and medulloblastoma.
@en
Targeting brain cancer: advanc ...... nt glioma and medulloblastoma.
@nl
prefLabel
Targeting brain cancer: advanc ...... nt glioma and medulloblastoma.
@en
Targeting brain cancer: advanc ...... nt glioma and medulloblastoma.
@nl
P2860
P356
P1476
Targeting brain cancer: advanc ...... nt glioma and medulloblastoma.
@en
P2093
Eric C Holland
Jason T Huse
P2860
P2888
P304
P356
10.1038/NRC2818
P407
P577
2010-05-01T00:00:00Z